Overview

Aliyah Price provides guidance to health and life science industry clients on regulatory, compliance and transactional matters related to privacy, cybersecurity, artificial intelligence, clinical research and FDA regulatory issues. 

Privacy, Cybersecurity & Artificial Intelligence 

Aliyah advises clients across the health and life science industry on compliance issues related to the GDPR, HIPAA, the CCPA, other privacy statutes and regulations, and artificial intelligence laws. In particular, she helps clients stay up-to-date on emerging U.S. state privacy and artificial intelligence laws. Aliyah works closely with clients to draft and negotiate data protection agreements, consumer-facing privacy notices and policies, and internal privacy and artificial intelligence resources and procedures. Aliyah also guides clients through privacy and cybersecurity considerations in mergers and acquisitions. 

Clinical Trials & Research

Aliyah counsels clients in the life sciences industry, including pharmaceutical and medical device companies on issues related to clinical trials and drug research and development. She supports clients by negotiating and developing clinical trial agreements, informed consent forms, and vendor and CRO agreements. Aliyah also advises clients on data use issues in clinical trials, including collection and use of clinical data, genetic samples and de-identified data.

Prior Experience

Aliyah served as a legal extern in the corporate compliance department of a major health care provider, reviewing and revising HIPAA and other regulatory compliance policies. Aliyah also completed a legal internship with the FCC’s Telecommunications Access Policy Division, where she worked with the COVID-19 Telehealth Program and Rural Health Care Program.

Personal Interests

Aliyah enjoys hiking, baking, traveling and jogging.

Related Topics

Credentials

Bar Admissions

Maryland
District of Columbia

Education

William & Mary School of Law
J.D. magna cum laude, Order of the Coif, with concentration in Business Law, William & Mary Business Law Review (2022)

University of Denver
B.A. in Political Science and Spanish, cum laude, Phi Beta Kappa (2019)

Insights & Events

Latest
最新 June 2025

Texas Genomic Act: A New Era of Genetic Privacy Legislation

Including Prohibitions on Genetic Sequencing, Storage and Sale of Genomic Information
7 min read  
最新 January 2025

FDA Issues Detailed Guidance for Biopharma Industry on What Information to Provide to FDA About Use of AI Models

A Seven-Step Process and Detailed Recommendations for Submissions
6 min read  
最新 January 2025

FDA Makes Draft Guidance Available on Lifecycle Management and Marketing Submission Recommendations for AI-Enabled Device Software Functions and Requests Industry Input

6 min read  
Recorded Webinar December 04, 2024

One Year After Biden’s AI Executive Order: AI Compliance Programs & What Health & Life Sciences Companies Should Know - Webinar

1 min read  
最新 September 2024

Recap of the FDA and CTTI Public Workshop on AI in Drug Development

3 min read  
最新 August 2024

AI After the Election: Potential Differences Between a Harris Administration and a Second Trump Administration for Artificial Intelligence Regulation

8 min read  
最新 July 2024

FTC Updates Health Breach Notification Rule

14 min read  
News October 2023

Great North Innocence Project Recognizes Faegre Drinker Team with 2023 Pro Bono Champions of the Year Award

1 min read  
News September 2023

Faegre Drinker Represents Boston Scientific in $850M Acquisition of Relievant Medsystems, Inc.

2 min read  
最新 May 2023

To Convert or Not to Convert: Our Take on Rural Emergency Hospitals

7 min read  

Leadership & Community

Professional Associations

  • American Health Law Association

Honors

  • Faegre Drinker — Pro Bono Honor Roll, 2024
  • District of Columbia Courts — Capital Pro Bono Honor Roll, 2024
  • Great North Innocence Project — Pro Bono Champions of the Year, 2023